Synthetic analogues of huwentoxin-IV spider peptide with altered human Nav1.7/Nav1.6 selectivity ratios - Université de Nantes Access content directly
Conference Poster Year : 2021

Synthetic analogues of huwentoxin-IV spider peptide with altered human Nav1.7/Nav1.6 selectivity ratios

Abstract

Huwentoxin-IV (HwTx-IV), a peptide discovered in the venom of the Chinese bird spider Cyriopagopus schmidti, has been reported to be a potent antinociceptive compound due to its action on the genetically validated NaV1.7 pain target. Using this peptide for antinociceptive applications in vivo suffers from one major drawback, namely its negative impact on the neuromuscular system. Although studied only recently, this effect appears to be due to an interaction between the peptide and the NaV1.6 channel subtype located at the presynaptic level. The aim of this work was to investigate how HwTx-IV could be modified in order to alter the original human (h) NaV1.7/NaV1.6 selectivity ratio of 23. Nineteen HwTx-IV analogues were chemically synthesized and tested for their blocking effects on the Na+ currents flowing through these two channel subtypes stably expressed in cell lines. Dose-response curves for these analogues were generated, thanks to the use of an automated patch-clamp system. Several key amino acid positions were targeted owing to the information provided by earlier structure-activity relationship (SAR) studies. Among the analogues tested, the potency of HwTx-IV E4K was significantly improved for hNaV1.6, leading to a decreased hNaV1.7/hNaV1.6 selectivity ratio (close to 1). Similar decreased selectivity ratios, but with increased potency for both subtypes, were observed for HwTx-IV analogues that combine a substitution at position 4 with a modification of amino acid 1 or 26 (HwTx-IV E1G/E4G and HwTx-IV E4K/R26Q). In contrast, increased selectivity ratios (> 46) were obtained if the E4K mutation was combined to an additional double substitution (R26A/Y33W) or simply by further substituting the C-terminal amidation of the peptide by a carboxylated motif, linked to a marked loss of potency on hNaV1.6 in this latter case. These results demonstrate that it is possible to significantly modulate the selectivity ratio for these two channel subtypes in order to improve the potency of a given analogue for hNaV1.6 and/or hNaV1.7 subtypes. In addition, selective analogues for hNaV1.7, possessing better safety profiles, were produced to limit neuromuscular impairments.
Fichier principal
Vignette du fichier
RT27-MONTNACH.pdf (154.17 Ko) Télécharger le fichier
Origin : Files produced by the author(s)

Dates and versions

hal-04470224 , version 1 (21-02-2024)

Identifiers

  • HAL Id : hal-04470224 , version 1

Cite

Ludivine Lopez, Jérôme Montnach, Barbara Oliveira-Mendes, Baptiste Thomas, Cécile Caumes, et al.. Synthetic analogues of huwentoxin-IV spider peptide with altered human Nav1.7/Nav1.6 selectivity ratios. RT27 – 27th Meeting of the French Society of Toxinology – Toxins: Mr Hyde or Dr Jekyll?, Dec 2021, Paris (Virtual), France. ⟨hal-04470224⟩
14 View
4 Download

Share

Gmail Facebook X LinkedIn More